These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
769 related articles for article (PubMed ID: 31642641)
1. Seroprevalence of measles, mumps, rubella, and varicella zoster virus antibodies among healthcare students: analysis of vaccine efficacy and cost-effectiveness. Ödemiş Í; Köse Ş; Akbulut Í; Albayrak H Rev Esp Quimioter; 2019 Dec; 32(6):525-531. PubMed ID: 31642641 [TBL] [Abstract][Full Text] [Related]
2. Do HIV-positive adult immigrants need to be screened for measles-mumps-rubella and varicella zoster virus immunization? Llenas-García J; Rubio R; Hernando A; Arrazola P; Pulido F AIDS Care; 2013 Aug; 25(8):980-9. PubMed ID: 23244745 [TBL] [Abstract][Full Text] [Related]
3. Immunogenicity and reactogenicity of a single dose of live attenuated varicella vaccine and a booster dose of measles-mumps-rubella vaccine given concomitantly at 12 years of age. Parment PA; Svahn A; Rudén U; Bråkenhielm G; Storsaeter J; Akesson L; Linde A Scand J Infect Dis; 2003; 35(10):736-42. PubMed ID: 14606613 [TBL] [Abstract][Full Text] [Related]
4. [Seroprevalence of antibodies against measles, rubella, mumps and varicella among school children in Madrid]. Gil Miguel A; Astasio Arbiza P; Ortega Molina P; Domínguez Rojas V; González López A An Esp Pediatr; 1999 May; 50(5):459-62. PubMed ID: 10394183 [TBL] [Abstract][Full Text] [Related]
5. [Antibody titers against measles, rubella, mumps and varicella-zoster viruses in medical students]. Yoshida N; Tsumura N; Toyomasu K; Sagawa K Sangyo Eiseigaku Zasshi; 2007 Jan; 49(1):21-6. PubMed ID: 17303935 [TBL] [Abstract][Full Text] [Related]
6. Prevalence of measles, mumps, rubella, and varicella susceptibility among health science students in a University in India. Arunkumar G; Vandana KE; Sathiakumar N Am J Ind Med; 2013 Jan; 56(1):58-64. PubMed ID: 22467356 [TBL] [Abstract][Full Text] [Related]
7. Seroprevalence of measles- and mumps-specific immunoglobulin G among Japanese healthcare students increased during 2007-2012. Kimura T; Tsunekawa K; Ogiwara T; Tokue Y; Nara M; Inoue T; Obuchi T; Suto C; Ohshima K; Murakami M Jpn J Infect Dis; 2013; 66(5):411-5. PubMed ID: 24047740 [TBL] [Abstract][Full Text] [Related]
8. Seroepidemiology of hepatitis viruses, measles, mumps, rubella and varicella among healthcare workers and students: Should we screen before vaccination? Karadeniz A; Akduman Alaşehir E J Infect Public Health; 2020 Apr; 13(4):480-484. PubMed ID: 32113699 [TBL] [Abstract][Full Text] [Related]
9. Immunogenicity and safety assessments after one and two doses of a refrigerator-stable tetravalent measles-mumps-rubella-varicella vaccine in healthy children during the second year of life. Schuster V; Otto W; Maurer L; Tcherepnine P; Pfletschinger U; Kindler K; Soemantri P; Walther U; Macholdt U; Douha M; Pierson P; Willems P Pediatr Infect Dis J; 2008 Aug; 27(8):724-30. PubMed ID: 18600190 [TBL] [Abstract][Full Text] [Related]
10. Assessment of immune status against measles, mumps, and rubella in young Kuwaitis: MMR vaccine efficacy. Madi N; Altawalah H; Alfouzan W; Al-Nakib W; Al-Roumi E; Jeragh A J Med Virol; 2020 Aug; 92(8):963-970. PubMed ID: 31919861 [TBL] [Abstract][Full Text] [Related]
11. Antibody persistence for 3 years following two doses of tetravalent measles-mumps-rubella-varicella vaccine in healthy children. Knuf M; Zepp F; Helm K; Maurer H; Prieler A; Kieninger-Baum D; Douha M; Willems P Eur J Pediatr; 2012 Mar; 171(3):463-70. PubMed ID: 21935584 [TBL] [Abstract][Full Text] [Related]
12. Antibody persistence in children aged 6-7years one year following booster immunization with two MMR vaccines applied by aerosol or by injection. Díaz Ortega JL; Castaneda D; Arellano Quintanilla DM; Martínez D; Trumbo SP; Fernández de Castro J Vaccine; 2017 May; 35(23):3116-3122. PubMed ID: 28457672 [TBL] [Abstract][Full Text] [Related]
13. The risk of measles, mumps, and varicella among young adults: a serosurvey of US Navy and Marine Corps recruits. Struewing JP; Hyams KC; Tueller JE; Gray GC Am J Public Health; 1993 Dec; 83(12):1717-20. PubMed ID: 8259801 [TBL] [Abstract][Full Text] [Related]
14. Changes in the prevalence of the measles, rubella, varicella-zoster, and mumps virus antibody titers in Japanese pregnant women. Hanaoka M; Hisano M; Watanabe N; Sugawara K; Kambe Y; Kanda E; Sago H; Kato T; Yamaguchi K Vaccine; 2013 May; 31(19):2343-7. PubMed ID: 23523405 [TBL] [Abstract][Full Text] [Related]
15. Seroprevalence of measles, mumps and rubella antibodies in Luxembourg: results from a national cross-sectional study. Mossong J; Putz L; Schneider F Epidemiol Infect; 2004 Jan; 132(1):11-8. PubMed ID: 14979584 [TBL] [Abstract][Full Text] [Related]
16. High seroprevalence of varicella, measles, mumps, rubella and pertussis antibodies in first-grade medical students. Socan M; Berginc N Wien Klin Wochenschr; 2008; 120(13-14):422-6. PubMed ID: 18726668 [TBL] [Abstract][Full Text] [Related]
17. [Epidemiological analysis of immunity against vaccine-preventable diseases: rubella, measles, mumps and chickenpox]. Buxbaum S; Doerr HW; Allwinn R Dtsch Med Wochenschr; 2001 Nov; 126(46):1289-93. PubMed ID: 11709730 [TBL] [Abstract][Full Text] [Related]
18. Measles, Mumps, and Rubella Serostatus and Response to MMR Vaccination Among HIV-Infected Adults. Singh HK; Chiu YL; Wilkin T AIDS Patient Care STDS; 2015 Sep; 29(9):461-4. PubMed ID: 26153909 [No Abstract] [Full Text] [Related]
19. Seroconversion rates to combined measles-mumps-rubella-varicella vaccine of children with upper respiratory tract infection. Dennehy PH; Saracen CL; Peter G Pediatrics; 1994 Oct; 94(4 Pt 1):514-6. PubMed ID: 7936862 [TBL] [Abstract][Full Text] [Related]
20. Measles, mumps, rubella and varicella antibodies among international and domestic university students. Dyda A; Broome A; Rawlinson W; Mahimbo A; Saha A; Kefalas B; Seale H; Macintyre CR; Zwar N; Gidding HF; Heywood AE J Travel Med; 2024 Jan; 31(1):. PubMed ID: 38195239 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]